| Literature DB >> 26614398 |
Sofía del Carmen1, Sonia Gatius2, Guzmán Franch-Arcas1, José Antonio Baena2, Oscar Gonzalez3, Carlos Zafon3, Dolors Cuevas2, Joan Valls2, Angustias Pérez1, Mercedes Martinez1, Susana Ros2, Carmen García Macías1, Carmela Iglesias3, Xavier Matías-Guiu4, Enrique de Álava5.
Abstract
Tumor resection in papillary thyroid carcinoma (PTC) is often accompanied by lymph node (LN) removal of the central and lateral cervical compartments. One-step nucleic acid amplification (OSNA) is a polymerase chain reaction-based technique that quantifies cytokeratin 19 (CK19) messenger RNA copies. Our aim is to assess the value of OSNA in detection of LN metastases in PTC, in comparison with imprints and microscopic analysis of formalin-fixed, paraffin-embedded (FFPE) tissue. A total of 387 LNs from 37 patients were studied. From each half LN, 2 imprints were taken and analyzed with hematoxylin and eosin (H&E) and CK19 immunostaining. One half of the LN was submitted to OSNA and one half to FFPE processing and H&E and CK19 staining. For concordance analysis, every single LN was considered as a case. A group of 11 cases with discordant results between OSNA and H&E/CK19 FFPE sections were subjected to additional FFPE serial sectioning and H&E and CK19 staining. We found a high degree of concordance between the assays used, with sensitivities ranging from 0.81 to 0.95, and specificities ranging from 0.87 and 0.98. OSNA allowed upstaging of patients from pN0 to pN1, in comparison with standard pathologic analysis. Identification of a metastatic LN with more than 15000 CK19 messenger RNA copies predicted the presence of a second LN with macrometastasis (<5000 copies). In summary, the study shows that OSNA application in sentinel or suspicious LN may be helpful in assessing nodal status in PTC patients.Entities:
Keywords: Lymph node; Metastasis; OSNA; Papillary carcinoma; Thyroid
Mesh:
Substances:
Year: 2015 PMID: 26614398 DOI: 10.1016/j.humpath.2015.09.020
Source DB: PubMed Journal: Hum Pathol ISSN: 0046-8177 Impact factor: 3.466